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EDITORIAL
Ensuring the Future of Rheumatology: A Multi-Dimensional Challenge and
Call to Action
William F. Harvey,1 Afton L. Hassett,2 and Sharad Lakhanpal3
The article by Bolster et al in this issue of Arthritis &
Rheumatology (1) and an article by Battafarano et al
recently published in Arthritis Care & Research (2) project a
startling picture of the future of the rheumatology workforce
in the US. The 2015 Rheumatology Workforce study
describes how, based on a variety of contributing factors,
there will be inadequate numbers of practicing rheumatolo-
gists and rheumatology health professionals to care for
patients with rheumatic and musculoskeletal diseases in the
coming years. It further describes how limitations in our
training pipeline may exacerbate this situation. These two
important articles serve as a call to action to understand and
address the wide range of factors that contribute to these
issues. This will require important strategic initiatives by pro-
fessional societies, government, practice groups, and training
programs in order to assure a healthy and vibrant rheuma-
tology workforce. Indeed, the new strategic plan for the
American College of Rheumatology (ACR) represents an
important starting point for this process. In this editorial, we
will summarize some key workforce study findings
presented in the articles by Bolster et al (1) and
Battafarano et al (2) and highlight some of the key
strategies to consider as we rise to meet these challenges.
Key factors affecting the rheumatology workforce
The 2015 Rheumatology Workforce Study high-
lighted several factors that underlie the challenges
ahead, which can best be summarized as monumental
problems with both supply and demand. The demand
for rheumatologists will be driven by the changing
demographics of the US. As described by Battafarano
et al (2), predictably, as our population ages and the
prevalence of some rheumatic diseases increases, we
will need more providers to care for these patients.
More intriguing, however, are some heretofore unde-
scribed supply factors that will have a dramatic impact.
The same aging demographic that will result in increas-
ing the prevalence of rheumatic disease will also lead
to the impending retirement of a significant portion of
our workforce. The generations of baby boomers and
their children are proportionately larger than the gen-
erations that follow, resulting in a shrinking workforce.
Perhaps one of the most important contributions
of this workforce study are the novel findings based on
two other important demographic shifts. Our specialty is
privileged to be an attractive one for women; this is to the
betterment of our society and to the population of women
who are often disproportionately affected by autoimmune
diseases. Women in medicine tend to feel the responsibili-
ties of maintaining a work-life balance more acutely than
men do. As such, many women in medicine choose to
work part time. Factoring this reality into the data is a
major methodologic advance represented in the 2015
Rheumatology Workforce Study. There are also newly
anticipated generational differences, with millennials of
both sexes expected to place even greater value on work-
life balance in a way that will also result in more providers
choosing not to work full time. The answer to this is not
to question their work ethic or dedication, but rather to
embrace strategies that will welcome more millennials
into the workforce. Necessarily, a wide array of actions
will be needed and every rheumatologist and rheumatol-
ogy health professional has a role to play in our future, as
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do our professional societies, our government, and our
patients. We will highlight some of the most important
actions we can take to help avert the predictions given in
the two workforce study articles.
Improve recruitment and training
When we reflect on how we chose rheumatology,
often we can point to an experience during our training.
It was frequently a caring mentor, a challenging case, an
inspirational attending physician, or early exposure to
the intriguing nature of rheumatology that was most
influential. Medical training necessarily focuses on the
breadth of the field, but we must ensure that exposure
to rheumatology happens in a meaningful way through-
out the long journey of training. All medical school
graduates should attain a basic level of knowledge and
skills about rheumatic and musculoskeletal diseases
during undergraduate medical education. Further, fun-
damental musculoskeletal and rheumatology curricula
should be included in primary care residency training
programs.
We need to elevate rheumatologists to positions of
prominence in communities, hospitals, universities, and
departments of medicine. As medical school curricula
shift to earlier exposure to clinical experience, we need
rheumatologists volunteering as small group preceptors,
physical examination instructors, and career mentors. We
need rheumatology practitioners to reach out to local
schools and communities and engage in the unique and
invaluable mentorship and teaching that they can provide.
We need curricula that highlight the depth and complexity
of medicine embodied in our specialty. We need our
women and men to support all students, trainees, and fac-
ulty, but especially women and underrepresented minori-
ties at each stage of their career so that they see our
specialty as their natural home within medicine. There is
a need for rheumatology mentoring of medical students
and residents.
We challenge every rheumatologist, in academic
settings or private practice, to find a way to inspire a new
trainee in our field. Further, when we are successful in
our endeavors to inspire the next generation of rheuma-
tology professionals, we need adequate numbers of and
funding for training programs. While the number of stu-
dents entering medical school has risen substantially, the
number of residency and fellow training slots has not.
There is a need for increased graduate medical education
funding to add more rheumatology fellowship training
programs. That likely will require both new and larger
programs and a renewed commitment from governments,
universities, and professional organizations such as the
ACR, Rheumatology Research Foundation (RRF), and
Arthritis Foundation, to step up and provide funding.
Address retention and distribution
Less often discussed is the distribution of rheuma-
tologists within the country, and this is particularly evident
in pediatrics. There are a significant number of states
without a single pediatric rheumatologist, and most
pediatric rheumatologists work in academic and urban
settings. Even in states like Massachusetts with robust
numbers of rheumatologists, there are localities across
the state and in neighboring ones where “rheumatology
deserts” exist. Encouraging qualified candidates from
underserved areas to enter rheumatology training may
help mitigate shortages in those areas, since these new
trainees will be more likely to go back to their native
regions. Therefore, we must strive to create new rheuma-
tology training programs in regions that do not have one
while also creating more training positions nationally. In
many specialties, including family medicine, data suggest
that trainees are most likely to practice within 50–100
miles of their training program (3), and so more training
positions in Boston, New York, and San Francisco cannot
be the only approach. We also need to focus on creating
incentives, government and otherwise, for rheumatology
providers to choose to practice where they are most
needed. There is a need to enable international rheuma-
tology trainees to stay in the US and not have to return to
their home countries after training. Visa programs should
be developed that will allow international trainees to stay
here and encourage them to work in underserved areas.
Finally, student loan forgiveness programs, especially for
pediatric rheumatology, will help to attract bright young
physicians into rheumatology.
Promote scientific discovery
Rheumatology saw a boom in interest following
the advent of biologic therapies. The impact of these
therapies on our patients and our specialty cannot be
overstated; however, it is likely that some of the decreased
interest in our specialty in recent years is due to two
related factors (4). The first factor is the lack of new ther-
apies in many disease areas. There were only one or two
novel drugs approved in rheumatology in each of the last
three years. Second, there is a marked slow-down in
investment in research. The breakthrough therapies that
will entice the next generation to enter our field are
threatened by inadequate funding for biomedical research
that fails to keep pace with general economic indices of
growth. Decline in funding also threatens the pipeline of
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the next generation of rheumatology researchers who will
make the discoveries and treat the patients who will des-
perately need our services. There seems to be a trend
among academic rheumatologists to move into private
practice for financial reasons and better job security. This
is a challenge when we need to add to and develop new
training programs. Thus, there is a critical need for
increased funding for rheumatology research in order to
realize the cures our patients envision and increase faculty
retention to train future rheumatology professionals.
Tackle reimbursement and payment redesign
Rheumatologists earn less than many other spe-
cialists in medicine (5), and with the rising cost of medi-
cal training (6) many potential candidates choose more
lucrative specialties. Therefore, our efforts to improve
reimbursement for services not only affect the health of
existing practices but incentivize future generations. The
ACR and many other organizations spend a great deal of
time advocating for changes to provider reimbursement
with this fact in mind. As the payment paradigm shifts
from fee for service to value-based payment, we see both
threats and opportunities. Current programs designed to
create value-based incentives, such as the Physician
Quality Reporting System, the Merit-based Incentive
Payment System, and Accountable Care Organizations,
are wholly inadequate with respect to appropriate recog-
nition of and reimbursement for the scope of services we
provide. Because we believe unquestionably that
rheumatologists provide the best value to patients with
rheumatic diseases, the ACR seeks to develop payment
models designed by, and intended for, practicing
rheumatologists. By shifting partially away from office-
based encounters to supporting important activities such
as care coordination, consultation expertise, telephone
and telemedicine encounters, and multidisciplinary care
teams, physician-focused payment models could help us
do more with less.
Leaders in government do not understand how
best to care for patients with rheumatic disease, and so we
must continue efforts in advocacy to educate them and
provide solutions and a path forward. We should advocate
to reduce administrative and practice hassles by reducing
insurance barriers and health care regulations. A fair
amount of time is spent every day in these unproductive
activities by providers and their staff. If these could be
eliminated, more time could be spent by rheumatologists
and rheumatology health care providers in patient care. It
may also encourage physicians considering retirement for
these reasons to continue in the workforce. Elimination
of these barriers to patient care may incentivize retired
rheumatologists and care providers to consider returning
to work in part-time or locum positions.
Enhance workforce diversity
The stark numbers presented by both Bolster et al
(1) and Battafarano et al (2) require innovative solutions.
Even doubling the number of trainees completing fellow-
ship programs will be insufficient. Creating a new payment
model that helps us keep patients who don’t need it out of
the hospital and, to some extent, out of our offices will
likewise be insufficient. To meet the looming workforce
shortage we will need to find new ways to work with other
physicians and other health professionals to supplement
the care we provide. The current state of education for
nurse practitioners (NPs) and physician assistants (PAs)
largely misses rheumatology, and this will have to change.
Practices wishing to hire these individuals must often train
them on the job with few resources. To promote the
preparation of NPs and PAs for the care of our patients,
the Association of Rheumatology Health Professionals
(ARHP) recently developed the NP/PA Rheumatology
Curriculum Outline. To help support the costs of training,
the RRF will support Mentored NP/PA Education
Awards to help bring these high-value providers on board.
Yet, too few NPs and PAs are drawn to rheumatology—
this is due in part to a lack of outreach and exposure to
educational programs. Effective outreach and promotion
of the benefits of the field are required. Revisiting prac-
tice models will be required to maximize the workforce.
For example, physical and occupational therapists, nurses,
behavioral scientists, and practice managers trained in
maximizing reimbursement and efficiency are poised to
have an important impact as well. Many of these efforts
are well underway, but more must be done.
Conclusions
The ACR and the ARHP have several key mis-
sions, among them education, research, advocacy, and
patient care. It is easy to see that meeting the projected
workforce shortage requires activity from the full breadth
of our efforts. The latest ACR strategic plan (7) challenges
the entire College to understand how the work they do
will benefit our workforce and increase the numbers of
rheumatologists and rheumatology health professionals
available to meet this need. We will likewise need training
programs and their academic affiliates to work at local
levels to bolster our numbers. And because the practice
community represents the linchpin of our connection to
patients and communities, we will need to find more ways
to ensure their survival and create opportunities for
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growth. The ACR and ARHP remain focused on ensuring
a vibrant future for our providers and for the growing num-
ber of patients who will surely need us.
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